Publications

management of hepatitis c virus (hcv) infection in drug substitution programs.

in switzerland, intravenous drug use (idu) accounts for 80% of newly acquired hepatitis c virus (hcv) infections. early hcv treatment has the potential to interrupt the transmission chain and reduce morbidity/mortality due to decompensated liver cirrhosis and hepatocellular carcinoma. nevertheless, patients in drug substitution programs are often insufficiently screened and treated.